NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-127-1998-0-US-01 AAV5 AND USES THEREOF US 60/087,029 Abandoned
NHLBI E-196-1998-1-US-01 Pressure Mediated Selective Delivery of Therapeutic Substances US 60/087,099 Abandoned
NCI E-167-1997-0-JP-05 The Use of A Nitroxide or a Prodrug Thereof in the Prophylactic and Therapeutic Treatment of Cancer JP National Stage 500817/1999 Abandoned
NCI E-167-1997-0-CA-04 THE USE OF A NITROXIDE OR A PRODRUG THEREOF IN THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF CANCER CA National Stage 2289017 Abandoned
NCI E-167-1997-0-DE-12 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects DE EP 98923772.2 Abandoned
NCI E-167-1997-0-FR-11 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects FR EP 98923772.2 Abandoned
NCI E-167-1997-0-EP-06 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects EP National Stage 98923772.2 Abandoned
NCI E-167-1997-0-NL-18 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects NL EP 98923772.2 Abandoned
NCI E-167-1997-0-LU-16 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects LU EP 98923772.2 Abandoned
NCI E-167-1997-0-MC-17 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects MC EP 98923772.2 Abandoned
NCI E-167-1997-0-GB-23 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects GB EP 98923772.2 Abandoned
NCI E-167-1997-0-DK-10 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects DK EP 98923772.2 Abandoned
NCI E-167-1997-0-GR-13 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects GR EP 98923772.2 Abandoned
NCI E-167-1997-0-IT-15 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects IT EP 98923772.2 Abandoned
NCI E-167-1997-0-IE-14 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects IE EP 98923772.2 Abandoned
NCI E-167-1997-0-ES-20 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects ES EP 98923772.2 Abandoned
NCI E-167-1997-0-CH-22 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects CH EP 98923772.2 Abandoned
NCI E-167-1997-0-SE-21 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects SE EP 98923772.2 Abandoned
NCI E-167-1997-0-PT-19 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects PT EP 98923772.2 Abandoned
NCI E-167-1997-0-AT-08 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects= AT EP 98923772.2 Abandoned
NCI E-167-1997-0-BE-09 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects BE EP 98923772.2 Abandoned
NCI E-167-1997-0-AU-03 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer due to Genetic Defects AU National Stage 75987/98 Abandoned
NCI E-167-1997-0-PCT-02 The Use of a Nitroxide and a Prodrug Thereof in the Prophylactic and Therapeutic Treatment of Cancer PCT PCT PCT/US1998/010685 Expired
NIAID E-032-1994-0-US-02 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF THE ENVELOPE 1 AND CORE GENES OF ISOLATES OF HEPATITIS C VIRUS AND USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC METHODS AND VACCINES US DIV 09/084,691 7070790 Abandoned PDF
CC E-142-1998-0-US-01 Labeling DNA Plasmids with Triplex-Forming Oligonucleotides, and Methods for Assaying Distribution of DNA Plasimids in Vivo US 60/086,704 Abandoned
NIAID E-089-1997-2-BR-03 PRODUCTION OF PARAINFLUENZA VIRUS FROM CLONED NUCLEOTIDE SEQUENCES BR National Stage PI9809456-4 Abandoned
NIAID E-089-1997-2-DE-16 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES DE EP 98926055.9 Abandoned
NIAID E-089-1997-2-FR-18 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES FR EP 98926055.9 Abandoned
NIAID E-089-1997-2-EP-05 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES EP National Stage 98926055.9 Abandoned
NIAID E-089-1997-2-CH-15 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES CH EP 98926055.9 Abandoned
NIAID E-089-1997-2-GB-19 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES GB EP 98926055.9 Abandoned
NIAID E-089-1997-2-ES-17 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES ES EP 98926055.9 Abandoned
NIAID E-089-1997-2-IT-20 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES IT EP 98926055.9 Abandoned
NIAID E-089-1997-2-JP-06 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS FROM CLONED NUCLEOTIDE SEQUENCES JP National Stage 10-550704 Abandoned
NIAID E-089-1997-3-US-01 Production of Attenuated Parainfluenza Virus Vaccines From Cloned Nucleotide Sequences US CIP 09/083,793 7208161 Abandoned PDF
NIAID E-089-1997-2-KR-07 PRODUCTION OF PARAINFLUENZA VIRUS FROM CLONED NUCLEOTIDE SEQUENCES KR National Stage 7010859/1999 Abandoned
NIAID E-089-1997-2-PCT-01 PRODUCTION OF PARAINFLUENZA VIRUS FROM CLONED NUCLEOTIDE SEQUENCES PCT PCT COMB PCT/US1998/010551 Expired
NCI E-143-1998-0-US-01 NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF US 60/086,487 Abandoned
NIAID E-089-1997-2-AU-08 PRODUCTION OF ATTENTUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES AU National Stage 77977/98 Abandoned
NIAID E-089-1997-2-CA-10 PRODUCTION OF PARAINFLUENZA VIRUS FROM CLONED NUCLEOTIDE SEQUENCES CA National Stage 2291216 Abandoned
NCI E-166-1997-0-AU-03 RESONANT STRUCTURE FOR SPATIAL AND SPECTRAL-SPATIAL IMAGING OF FREE RADICAL SPIN PROBES USING RADIOFREQUENCY TIME DOMAIN ELECTRON... AU National Stage 76915/98 Abandoned
NCI E-166-1997-0-PCT-02 RESONANT STRUCTURE FOR SPATIAL AND SPECTRAL-SPATIAL IMAGING OF FREE RADICAL SPIN PROBES USING RADIOFREQUENCY TIME DOMAIN ELECTRON... PCT PCT PCT/US1998/010467 Expired
NCI E-166-1997-0-JP-06 RESONANT STRUCTURE FOR SPATIAL AND SPECTRAL-SPATIAL IMAGING OF FREE RADICAL SPIN PROBES USING RADIOFREQUENCY TIME DOMAIN ELECTRON... JP National Stage 11-500774 Abandoned
NCI E-166-1997-0-EP-05 RESONANT STRUCTURE FOR SPATIAL AND SPECTRAL-SPATIAL IMAGING OF FREE RADICAL SPIN PROBES USING RADIOFREQUENCY TIME DOMAIN ELECTRON... EP National Stage 98924837.2 Abandoned
NHLBI E-196-1998-0-US-01 Pressure Mediated Selective Delivery of Therapeutic Substances US 60/086,565 Abandoned
NCI E-166-1997-0-CA-04 RESONANT STRUCTURE FOR SPATIAL AND SPECTRAL-SPATIAL IMAGING OF FREE RADICAL SPIN PROBES USING RADIOFREQUENCY TIME DOMAIN ELECTRON... CA National Stage 2290626 Abandoned
NCI E-059-1992-1-US-03 Calanolide and Related Antiviral Compounds, Compositions, and Uses Thereof US CON 09/083,249 6774141 Expired PDF
NCI E-181-1997-0-PCT-02 METHOD AND COMPOSITIONS FOR MAKING DENDRITIC CELLS FROM EXPANDED POPULATIONS OF MONOCYTES PCT PCT PCT/US1998/010311 Expired
NCI E-181-1997-0-EP-03 METHOD AND COMPOSITIONS FOR MAKING DENDRITIC CELLS FROM EXPANDED POPULATIONS OF MONOCYTES AND FOR ACTIVATING CELLS EP National Stage 98922449.8 Abandoned
NIDCR E-222-1998-0-US-01 Spatially Aligned Conjugated Composition Having a Thioether Bond Linkage US ORD 09/079,374 6086881 Expired PDF